FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
CNN
The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.
The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease. Donanemab, made by Indianapolis-based Eli Lilly, works by helping the body remove amyloid plaque buildup in the brain, a hallmark of Alzheimer’s disease. Lilly said it will be sold under the name Kisunla and would cost $695 per vial before insurance, what would amount to $12,522 for a six-month course or about $32,000 for a year, depending on when the patient would complete their treatment. Donanemab is not a cure, but clinical trials showed that it slowed the progression of Alzheimer’s, allowing the patient to live an independent life for longer and safely participate in everyday activities. Lilly told a committee of FDA advisers in June that late-stage clinical research data showed “highly meaningful results” for patients who took donanemab, with about 35% lower risk of progression of the disease over a year and a half compared with patients who got a placebo. The FDA advisers voted that the treatment appeared safe and effective. While rare, there were some serious adverse events during the drug trial, Lilly told the committee, occurring in only 2% of patients. The patients who took the donanemab had a slightly higher mortality rate — 2%, compared with 1.7% in the placebo arm of the trial.
The first measles cases hit the region last fall, and the South Carolina health department declared an outbreak at the start of October. Now, more than 200 cases have been reported over the past few months, and there are no signs of slowing.
New US dietary guidelines released Wednesday echo past advice, but also include nods to US Health and Human Services Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” movement — urging Americans to prioritize protein and “healthy fats” and limit their consumption of ultraprocessed foods and added sugar.
After the Trump administration announced sweeping changes to the US childhood vaccine schedule this week, parents and pediatricians are trying to make sense of what’s driving the change and how it will affect families.
From Rolls-Royce to Aston Martin, high-end carmakers are catering to their wealthiest clients through bespoke projects where no ask is too much.
The US Department of Health and Human Services is recommending fewer vaccines for most American children, health officials said Monday.
Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the week.
For political wives, the inauguration coat is an agenda-setter — a first statement on how someone who may or may not have aspired to be a public symbol will navigate the always-tricky, often exasperating world of appearing in public. Here’s how Zohran Mamdani’s wife handled it.
The United States reported more than 2,000 measles cases in 2025, federal data shows, a higher annual total than the country has seen in decades.
A growing number of shoppers are questioning the value of luxury goods, as videos criticizing the poor quality of high-end products go viral.
Most US states are experiencing high or very high flu activity, and levels continue to increase nationwide.